M. Charissoux

483 total citations
31 papers, 254 citations indexed

About

M. Charissoux is a scholar working on Pulmonary and Respiratory Medicine, Genetics and Cancer Research. According to data from OpenAlex, M. Charissoux has authored 31 papers receiving a total of 254 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 10 papers in Genetics and 10 papers in Cancer Research. Recurrent topics in M. Charissoux's work include Glioma Diagnosis and Treatment (10 papers), Breast Cancer Treatment Studies (8 papers) and Brain Metastases and Treatment (6 papers). M. Charissoux is often cited by papers focused on Glioma Diagnosis and Treatment (10 papers), Breast Cancer Treatment Studies (8 papers) and Brain Metastases and Treatment (6 papers). M. Charissoux collaborates with scholars based in France, United States and United Kingdom. M. Charissoux's co-authors include D. Azria, N. Aillères, P. Fenoglietto, O. Riou, Fabienne Bauchet, Amélie Darlix, Luc Bauchet, Valérie Rigau, Pascale Fabbro-Péray and Dominique Figarella‐Branger and has published in prestigious journals such as Journal of Clinical Oncology, Journal of neurosurgery and Magnetic Resonance in Medicine.

In The Last Decade

M. Charissoux

27 papers receiving 253 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Charissoux France 9 129 98 94 55 51 31 254
Giulio Alberto Carta Italy 9 91 0.7× 167 1.7× 68 0.7× 42 0.8× 46 0.9× 19 285
S. Cassani Italy 6 87 0.7× 190 1.9× 109 1.2× 70 1.3× 28 0.5× 12 311
Nathalie Casanova Switzerland 9 130 1.0× 83 0.8× 163 1.7× 68 1.2× 25 0.5× 17 322
Vimoj Nair Canada 11 114 0.9× 145 1.5× 76 0.8× 44 0.8× 30 0.6× 32 308
Petr Burkoň Czechia 10 178 1.4× 224 2.3× 67 0.7× 55 1.0× 35 0.7× 35 348
J.P. Bahary Canada 11 184 1.4× 202 2.1× 64 0.7× 53 1.0× 51 1.0× 21 388
Renate Haselmann Germany 7 148 1.1× 212 2.2× 86 0.9× 80 1.5× 43 0.8× 9 352
Alessandra Mirri Italy 9 111 0.9× 159 1.6× 45 0.5× 65 1.2× 65 1.3× 15 307
D. Hentati Tunisia 6 252 2.0× 166 1.7× 88 0.9× 41 0.7× 60 1.2× 16 357
Stefanie Brehmer Germany 9 177 1.4× 132 1.3× 60 0.6× 32 0.6× 17 0.3× 25 239

Countries citing papers authored by M. Charissoux

Since Specialization
Citations

This map shows the geographic impact of M. Charissoux's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Charissoux with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Charissoux more than expected).

Fields of papers citing papers by M. Charissoux

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Charissoux. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Charissoux. The network helps show where M. Charissoux may publish in the future.

Co-authorship network of co-authors of M. Charissoux

This figure shows the co-authorship network connecting the top 25 collaborators of M. Charissoux. A scholar is included among the top collaborators of M. Charissoux based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Charissoux. M. Charissoux is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mollévi, Caroline, M. Charissoux, Amélie Darlix, et al.. (2024). Prognostic impact of the number and total tumor burden of secondary cerebral lesions in patients with resected brain metastases of non–small cell lung cancers. Journal of neurosurgery. 141(1). 89–99. 4 indexed citations
2.
Tensaouti, Fatima, Julia Gilhodes, Bastien Cabarrou, et al.. (2023). Pseudoprogression in GBM versus true progression in patients with glioblastoma: A multiapproach analysis. Radiotherapy and Oncology. 181. 109486–109486. 8 indexed citations
3.
Riou, O., Florence Castan, Sophie Gourgou, et al.. (2022). Magnetic Resonance-Guided Reirradiation for Local Recurrence within the Prostate or in the Prostate Bed: One-Year Clinical Results of a Prospective Registry Study. Cancers. 14(8). 1943–1943. 11 indexed citations
4.
Riou, O., N. Aillères, M. Charissoux, et al.. (2021). Magnetic Resonance–Guided Reirradiation for Local Recurrence Within the Prostate or in the Prostate Bed: Preliminary Results of a Prospective Registry Study. Advances in Radiation Oncology. 6(5). 100748–100748. 13 indexed citations
5.
Russo, Domenica, et al.. (2021). A choroid plexus metastasis of a prostatic adenocarcinoma mimicking a choroid plexus carcinoma: A case report. Neurochirurgie. 68(1). 113–116. 3 indexed citations
6.
Bourgier, C., I. Latorzeff, P. Fénoglietto, et al.. (2019). Traitement des oligometastases et oligoprogression. Cancer/Radiothérapie. 23(6-7). 482–485. 1 indexed citations
7.
Du‐Thanh, A., et al.. (2019). Low- vs. Middle-dose Total Skin Electron Beam Therapy for Mycosis Fungoides: An Efficiency-based Retrospective Survey of Skin Response. Acta Dermato Venereologica. 99(6). 544–550. 5 indexed citations
8.
Ursu, Rénata, Laure Thomas, Dimitri Psimaras, et al.. (2019). Angiotensin II receptor blockers, steroids and radiotherapy in glioblastoma—a randomised multicentre trial (ASTER trial). An ANOCEF study. European Journal of Cancer. 109. 129–136. 13 indexed citations
9.
Fabbro-Péray, Pascale, Sonia Zouaoui, Amélie Darlix, et al.. (2018). Association of patterns of care, prognostic factors, and use of radiotherapy–temozolomide therapy with survival in patients with newly diagnosed glioblastoma: a French national population-based study. Journal of Neuro-Oncology. 142(1). 91–101. 66 indexed citations
10.
Kerr, Christine, et al.. (2016). Comparison of volumetric‐modulated arc therapy and dynamic conformal arc treatment planning for cranial stereotactic radiosurgery. Journal of Applied Clinical Medical Physics. 17(1). 92–101. 23 indexed citations
11.
Khalifa, Jonathan, Fatima Tensaouti, I. Catalaa, et al.. (2016). Do perfusion and diffusion MRI predict glioblastoma relapse sites following chemoradiation?. Journal of Neuro-Oncology. 130(1). 181–192. 19 indexed citations
13.
Khalifa, Jonathan, Fatima Tensaouti, Léonor Chaltiel, et al.. (2016). Identification of a candidate biomarker from perfusion MRI to anticipate glioblastoma progression after chemoradiation. European Radiology. 26(11). 4194–4203. 17 indexed citations
14.
Riou, O., B. Chauvet, J. L. Lagrange, et al.. (2016). Radiothérapie des cancers de vessie. Cancer/Radiothérapie. 20. S196–S199. 7 indexed citations
15.
Azria, D., et al.. (2015). Paramètres de radiosensibilité des cancers du sein. Cancer/Radiothérapie. 19(4). 237–240. 1 indexed citations
16.
Riou, O., P. Fenoglietto, C. Bourgier, et al.. (2015). Feasibility of accelerated partial breast irradiation with volumetric-modulated arc therapy in elderly and frail patients. Radiation Oncology. 10(1). 209–209. 9 indexed citations
17.
Bauchet, Luc, Sonia Zouaoui, Amélie Darlix, et al.. (2015). Patterns of care for 1,602 patients with newly diagnosed glioblastoma.. Journal of Clinical Oncology. 33(15_suppl). e13005–e13005. 2 indexed citations
18.
Mourrégot, Anne, C. Lemanski, Marian Gutowski, et al.. (2014). Day-care for breast cancer: Ambulatory surgery and intra-operative radiation. Techniques and preliminary results of the Centre Val-d’Aurelle – Montpellier. Journal of Visceral Surgery. 151. S3–S10. 5 indexed citations
19.
Chan‐Seng, Emilie, M. Charissoux, A. Larbi, et al.. (2014). Spinal Metastases in Breast Cancer: Single Center Experience. World Neurosurgery. 82(6). 1344–1350. 13 indexed citations
20.
Bourgier, C., C. Lemanski, O. Riou, et al.. (2013). Irradiation hypofractionnée à visée curative, standard thérapeutique des cancers du sein ?. Cancer/Radiothérapie. 17(7). 705–707. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026